ABBV logo

AbbVie (ABBV) Selling, General & Administrative Expenses

Annual SGA

$14.75 B
+$1.88 B+14.61%

December 1, 2024

Summary

Performance

1-Year Change

+14.61%

3-Year Change

+19.46%

5-Year Change

+112.5%

15-Year Change

+134.34%

ABBV SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.68%
ABBV annual SGA is higher than 99.68% of companies in Healthcare sector

High & Low

All-time High

$15.26 B
ABBV annual SGA is currently -3.33% below its historical high of $15.26 billion

3-Year Low

$12.35 B
ABBV annual SGA is currently +19.46% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
ABBV previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
ABBV next annual earnings announcement has not yet been scheduled

OtherABBVexpensesmetrics:

Annual Total Expenses

$47.20 B
ABBV annual total expenses is $47.20 billion

Annual Operating Expenses

$30.29 B
ABBV annual total operating expenses is $30.29 billion

Annual Cost Of Goods Sold

$16.90 B
ABBV annual cost of goods sold is $16.90 billion

Annual Interest Expense

-
ABBV annual interest expense value is unknown

Quarterly SGA

$3.85 B
-$350.00 M-8.32%

December 1, 2024

Summary

Performance

3-Month Change

-8.32%

1-Year Change

-8.32%

3-Year Change

-28.77%

5-Year Change

+97.59%

ABBV Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.49%
ABBV quarterly SGA is higher than 99.49% of companies in Healthcare sector

High & Low

All-time High

$5.41 B
ABBV quarterly SGA is currently -28.77% below its historical high of $5.41 billion

3-Year Low

$3.04 B
ABBV quarterly SGA is currently +26.85% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ABBV previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
ABBV next earnings announcement is scheduled for Apr 25, 2025

OtherABBVexpensesmetrics:

Quarterly Total Expenses

$16.59 B
ABBV quarterly total expenses is $16.59 billion

Quarterly Operating Expenses

$12.20 B
ABBV quarterly total operating expenses is $12.20 billion

Quarterly Cost Of Goods Sold

$4.40 B
ABBV quarterly cost of goods sold is $4.40 billion

Quarterly Interest Expense

-
ABBV quarterly interest expense value is unknown

TTM SGA

N/A

December 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ABBV TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$23.02 B
ABBV TTM SGA is currently at an all-time high

3-Year Low

-$12.12 B
ABBV TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ABBV previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
ABBV next earnings announcement is scheduled for Apr 25, 2025

OtherABBVexpensesmetrics:

Annual Total Expenses

$47.20 B
ABBV annual total expenses is $47.20 billion

Annual Operating Expenses

$30.29 B
ABBV annual total operating expenses is $30.29 billion

TTM Cost Of Goods Sold

$16.90 B
ABBV TTM cost of goods sold is $16.90 billion

TTM Interest Expense

-
ABBV TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$14.75 B
ABBV annual SGA is $14.75 billion

Annual Operating Expenses

$30.29 B
ABBV annual total operating expenses is $30.29 billion

Annual Cost Of Goods Sold

$16.90 B
ABBV annual cost of goods sold is $16.90 billion

ABBV Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.6%-8.3%-
3 y3 years+19.5%-28.8%-
5 y5 years+112.5%+97.6%-

ABBV Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.3%+19.5%-28.8%+26.9%
5 y5-year-3.3%+112.5%-28.8%+127.4%
alltimeall time-3.3%+340.6%-28.8%+270.3%

AbbVie Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$14.75 B(+14.6%)
$3.85 B(-8.3%)
$14.75 B(+4.7%)
Sep 2024
-
$4.21 B(+24.5%)
$14.09 B(+6.3%)
Jun 2024
-
$3.38 B(+1.9%)
$13.26 B(+0.8%)
Mar 2024
-
$3.31 B(+3.8%)
$13.15 B(+2.1%)
Dec 2023
$12.87 B(-15.6%)
$3.19 B(-5.3%)
$12.87 B(-1.7%)
Sep 2023
-
$3.37 B(+3.2%)
$13.10 B(+0.5%)
Jun 2023
-
$3.27 B(+7.5%)
$13.03 B(-14.1%)
Mar 2023
-
$3.04 B(-11.1%)
$15.17 B(-0.6%)
Dec 2022
$15.26 B(+23.6%)
$3.42 B(+3.4%)
$15.26 B(+1.0%)
Sep 2022
-
$3.30 B(-39.0%)
$15.10 B(+1.5%)
Jun 2022
-
$5.41 B(+73.1%)
$14.88 B(+17.8%)
Mar 2022
-
$3.13 B(-4.1%)
$12.63 B(+2.3%)
Dec 2021
$12.35 B(+9.3%)
$3.26 B(+5.7%)
$12.35 B(+0.2%)
Sep 2021
-
$3.08 B(-2.6%)
$12.32 B(+2.0%)
Jun 2021
-
$3.16 B(+11.3%)
$12.08 B(-2.9%)
Mar 2021
-
$2.84 B(-12.0%)
$12.45 B(+10.2%)
Dec 2020
$11.30 B(+62.8%)
$3.23 B(+13.5%)
$11.30 B(+12.8%)
Sep 2020
-
$2.85 B(-19.3%)
$10.02 B(+13.5%)
Jun 2020
-
$3.53 B(+108.1%)
$8.83 B(+26.9%)
Mar 2020
-
$1.70 B(-13.1%)
$6.96 B(+0.2%)
Dec 2019
$6.94 B(-6.2%)
$1.95 B(+17.7%)
$6.94 B(+0.3%)
Sep 2019
-
$1.66 B(+0.2%)
$6.92 B(-3.6%)
Jun 2019
-
$1.65 B(-1.5%)
$7.18 B(-1.5%)
Mar 2019
-
$1.68 B(-12.9%)
$7.29 B(-1.5%)
Dec 2018
$7.40 B(+17.5%)
$1.93 B(+0.5%)
$7.40 B(-0.4%)
Sep 2018
-
$1.92 B(+9.0%)
$7.43 B(+6.6%)
Jun 2018
-
$1.76 B(-1.7%)
$6.96 B(+3.7%)
Mar 2018
-
$1.79 B(-8.4%)
$6.71 B(+6.6%)
Dec 2017
$6.29 B
$1.96 B(+34.2%)
$6.29 B(+4.6%)
DateAnnualQuarterlyTTM
Sep 2017
-
$1.46 B(-3.4%)
$6.02 B(+1.3%)
Jun 2017
-
$1.51 B(+9.9%)
$5.94 B(+0.7%)
Mar 2017
-
$1.37 B(-18.2%)
$5.90 B(+0.3%)
Dec 2016
$5.88 B(-7.9%)
$1.68 B(+21.6%)
$5.88 B(-1.0%)
Sep 2016
-
$1.38 B(-5.8%)
$5.94 B(-1.5%)
Jun 2016
-
$1.47 B(+8.2%)
$6.03 B(-3.8%)
Mar 2016
-
$1.35 B(-22.0%)
$6.27 B(-1.8%)
Dec 2015
$6.39 B(-17.3%)
$1.74 B(+17.8%)
$6.39 B(-20.1%)
Sep 2015
-
$1.47 B(-13.4%)
$7.99 B(-1.5%)
Jun 2015
-
$1.70 B(+15.6%)
$8.11 B(+3.2%)
Mar 2015
-
$1.47 B(-55.9%)
$7.86 B(+1.7%)
Dec 2014
$7.72 B(+44.3%)
$3.34 B(+109.5%)
$7.72 B(+32.5%)
Sep 2014
-
$1.59 B(+10.2%)
$5.83 B(+6.1%)
Jun 2014
-
$1.45 B(+8.1%)
$5.50 B(+0.8%)
Mar 2014
-
$1.34 B(-7.5%)
$5.46 B(+1.9%)
Dec 2013
$5.35 B(+7.3%)
$1.45 B(+14.8%)
$5.35 B(+0.7%)
Sep 2013
-
$1.26 B(-10.3%)
$5.32 B(+3.4%)
Jun 2013
-
$1.41 B(+13.7%)
$5.14 B(+3.2%)
Mar 2013
-
$1.24 B(-12.3%)
$4.98 B(-0.2%)
Dec 2012
$4.99 B(-15.4%)
$1.41 B(+30.0%)
$4.99 B(+5.9%)
Sep 2012
-
$1.08 B(-12.9%)
$4.71 B(-23.6%)
Jun 2012
-
$1.25 B(-0.1%)
$6.17 B(+3.4%)
Mar 2012
-
$1.25 B(+9.9%)
$5.96 B(+1.2%)
Dec 2011
$5.89 B(+54.3%)
$1.13 B(-55.4%)
$5.89 B(+23.8%)
Sep 2011
-
$2.54 B(+144.1%)
$4.76 B(+114.5%)
Jun 2011
-
$1.04 B(-11.6%)
$2.22 B(+88.4%)
Mar 2011
-
$1.18 B
$1.18 B
Dec 2010
$3.82 B(+14.1%)
-
-
Dec 2009
$3.35 B
-
-

FAQ

  • What is AbbVie annual SGA?
  • What is the all time high annual SGA for AbbVie?
  • What is AbbVie annual SGA year-on-year change?
  • What is AbbVie quarterly SGA?
  • What is the all time high quarterly SGA for AbbVie?
  • What is AbbVie quarterly SGA year-on-year change?
  • What is the all time high TTM SGA for AbbVie?

What is AbbVie annual SGA?

The current annual SGA of ABBV is $14.75 B

What is the all time high annual SGA for AbbVie?

AbbVie all-time high annual SGA is $15.26 B

What is AbbVie annual SGA year-on-year change?

Over the past year, ABBV annual SGA has changed by +$1.88 B (+14.61%)

What is AbbVie quarterly SGA?

The current quarterly SGA of ABBV is $3.85 B

What is the all time high quarterly SGA for AbbVie?

AbbVie all-time high quarterly SGA is $5.41 B

What is AbbVie quarterly SGA year-on-year change?

Over the past year, ABBV quarterly SGA has changed by -$350.00 M (-8.32%)

What is the all time high TTM SGA for AbbVie?

AbbVie all-time high TTM SGA is $23.02 B